Effectiveness of @entity2892 in the treatment of chronic post-traumatic XXXX .

@entity1 @entity2892 @entity796 @entity294 @entity794 @entity281 @entity56 @entity4421
In 61 @entity1 the effectiveness of @entity2892 in the treatment of chronic post-traumatic @entity4421 was examined. The diagnosis of post-traumatic @entity4421 was based on clinical and radiological signs of @entity281 , as well as a positive bone culture from a surgical specimen. The average duration of treatment was 10 days with a dosage 3 X 500 mg @entity2892 daily. The most commonly identified pathogen was @entity794 . In 75% of the cases an @entity281 with Gram-positive pathogens was found. The majority of Gram-negative infections was caused by @entity796 . The rate of elimination was greater than 90% for both Gram-positive and Gram-negative bacteria. A definite cure was achieved in 80% of the reported cases, only four @entity1 (7%) showed a recurrence of the @entity281 . @entity56 or other adverse effects were not observed except for @entity294 in four @entity1 . The high rate of therapeutic effectiveness as well as the excellent toleration justify the use of @entity2892 in the treatment of chronic post-traumatic @entity4421 .
